Home/Filings/4/0001650664-24-000075
4//SEC Filing

Mei Baisong 4

Accession 0001650664-24-000075

CIK 0001650664other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:16 PM ET

Size

5.0 KB

Accession

0001650664-24-000075

Insider Transaction Report

Form 4
Period: 2024-06-04
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Transactions
  • Sale

    Common Stock

    2024-06-04$5.50/sh511$2,808141,032 total
Footnotes (1)
  • [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeother

Related Parties

1
  • filerCIK 0001938499

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:16 PM ET
Size
5.0 KB